Testicular cancer is mostly seen in young men. We planned this study that neutrophil-lymphocyte ratio (NLR) would help us predict the prognosis of the patients, except known markers such as AFP, hCG, and LDH.
Patients and Method:
Between 2015 and 2020, we conducted our study on 152 patients undergoing radical orchiectomy in our clinic. We divided our patients into good, moderate, and poor prognostic groups. We also created a control group of healthy patients of similar ages. We evaluated the NLR results in preoperative peripheral blood statistically among these groups.
Results:
We found a significant difference between the control group and the patient group, and between the good and moderate/poor prognostic groups for preoperative NLR.
Conclusion:
This study created the opinion that preoperative NLR will help us predict the prognosis of patients.
SiegelRLMillerKDJemalA.Cancer statics, 2016. CA Cancer J Clin2016; 66(1): 7–30.
2.
HuygheEMatsudaTThonneauP.İncreasing incidence of testicular cancer worldwide: a review. J Urol2003; 170: 5–11.
3.
ParkinDMWhelanSLFerlayJ, et al. Cancer incidence in five continents. Vol I to VII. IARC Cancerbase No. 7, Lyon: CancerMondial website, http://www-dep.iarc.fr/CI5_IX_frame.htm (2005, accessed May 2009).
4.
CuradoMPEdwardsBShinHR, et al. (eds.) 2007 Cancer incidence in five continents. Vol. IX. IARC Scientific Publications no. 160, Lyon: IARC CancerMondial website, http://www-dep.iarc.fr.fr/CI5_IX_frame.htm (2007, accessed May 2009).
5.
WuXGrovesFDMcLaughlinCC, et al. Cancer incidence patterns among adolecents and young adults in the United States. Cancer Causes Control2005; 16: 309–320.
6.
PettersonARichiardiLNordenskjoldA, et al. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med2007; 356(18): 1835–1841.
7.
CostabileRA.How worrisome is testicular microlitiasis?Curr Opin Urol2007; 17(6): 419–423.
8.
HemminkiKLiX.Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer2004; 90(9): 1765–1770.
9.
GregoryADHoughtonAM.Tumor associated neutrophils: new targets for cancer therapy. Cancer Res2011; 71: 24116.
10.
RoxburghCSCrozierJEMaxwellF, et al. Comparison of tumor-based (Peterson Index) and inflammation-based (Glasgow prognostic score) scoring system in patients undergoing curative resection for colon cancer. Br J Cancer2009; 100: 701.
11.
WeiYJiangYZQuianWH.Prognostic role of NLR in urinary system cancers: a meta-analysis. PLoS One2014; 9: e92079.
12.
TempletonAJMcNamaraMGSerugaB, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systemic review and meta-analysis. JNCI J Natl Cancer Inst2014; 106(6): dju124.
13.
TanYGSiaJHuangHH, et al. Neutrophil-to-Lymphocyte ratio independemtly predicts advanced pathological staging and poorer survival outcomes in testicular cancer. Investig Clin Urol2019; 60: 176–183.
14.
IlktacADoganBErsozC, et al. The relationship of neutrophil to lymphocyte ratio with testicular cancer. Int Braz J Urol2020; 46(1): 101–107.
15.
RoxburghCSMcMillanDC.Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol2010; 6(1): 149–163.
16.
ViganoABrueraEJhangriGS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med2000; 160(6): 861–868.
17.
GuthrieGJCharlesKARoxburghCS, et al. The systemic inflammation-based neuthrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol2013; 88(1): 218–230.
18.
PetrieHTKlassenLWKayHD.Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous perifheral blood granulocytes. J Immunol1985; 134(1): 230–234.
19.
el-HagAClarkRA.Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol1987; 139(7): 2406–2413.
20.
SchaiderHOkaMBogenriederT, et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL.8. Int J Cancer2003; 103: 33543.
Di CarloEForniGMusianiP. Neutrophils in the antitumoral immune response. Chem Immunol Allergy2003; 83: 182–203.
23.
McCourtMWanJHSookhaiS, et al. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol2001; 27(4): 396–403.
24.
JablonskaEKilukMMarkiewiczW, et al. TNF-alfa,IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther exp (Warsz)2001; 49(1): 63–69.
25.
FridlenderZGSunJKimS, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’ TAN. Cancer Cell2009; 16: 183–194.
26.
KusumantoYHDamWAHospersGA, et al. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis2003; 6: 2837.
